La vendita allo scoperto per Cannabis Suisse dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Cannabis Suisse. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Cannabis Suisse (OTC:CSUI) Azioni, Report sulle vendite allo scoperto

Cannabis Suisse Corp is engaged in the rental of commercial office and industrial space.

CANNABIS SUISSE CORP by Cannabis Suisse Corp.

Cannabis Suisse Corp

Morgan Stanley analyst Benjamin Swinburne maintains Warner Music Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WMG#NASDAQ">WMG</a>) with a Overweight and lowers the price target from $38 to $37.

News

Price Target

Analyst Ratings

Morgan Stanley Maintains Overweight on Warner Music Gr, Lowers Price Target to $37

Morgan Stanley analyst Matthew Cost maintains Unity Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>) with a Overweight and raises the price target from $24 to $26.

Morgan Stanley Maintains Overweight on Unity Software, Raises Price Target to $26

Biotech

General

Pfizer CEO Albert Bourla Says "Looking At Everything" In The Obesity Market Beyond Injectable GLP-1 Drugs; Says "All In" On Obesity Drug Development

Morgan Stanley analyst Vincent Andrews maintains Tronox Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TROX#NYSE">TROX</a>) with a Equal-Weight and lowers the price target from $16 to $12.

TROX

Morgan Stanley Maintains Equal-Weight on Tronox Holdings, Lowers Price Target to $12

Morgan Stanley analyst Matthew Cost maintains Trade Desk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) with a Overweight and raises the price target from $130 to $145.

Morgan Stanley Maintains Overweight on Trade Desk, Raises Price Target to $145

Morgan Stanley analyst Tejas Savant maintains Thermo Fisher Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>) with a Overweight and lowers the price target from $670 to $647.

Morgan Stanley Maintains Overweight on Thermo Fisher Scientific, Lowers Price Target to $647

<a href="https://www.bloomberg.com/news/articles/2025-01-13/lilly-asks-biden-administration-to-pause-drug-price-negotiations?srnd=homepage-europe">https://www.bloomberg.com/news/articles/2025-01-13/lilly-asks-biden-administration-to-pause-drug-price-negotiations?srnd=homepage-europe</a>
&nbsp;
Drugmaker Eli Lilly &amp; Co. has asked the US government to pause its forward march with drug-price negotiations, potentially thwarting the Biden administration's plans to release a new list of drug targets before leaving office next week.&nbsp;

Politics

'Lilly Asks Biden Administration to Pause Drug-Price Negotiations' - Bloomberg News

Insmed's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NYSE">INSM</a>) short percent of float has risen 18.59% since its last report. The company recently reported that it has 15.44 million shares sold short, which is 8.74% of all regular shares that are available for trading. Based on its trading volume, it would take traders 8.63 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Insmed Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736792122_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Insmed has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Insmed's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Insmed's peer group average for short interest as a percentage of float is 5.01%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

INSM

How Is The Market Feeling About Insmed?

GitLab's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NYSE">GTLB</a>) short percent of float has risen 45.91% since its last report. The company recently reported that it has 7.46 million shares sold short, which is 6.07% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.68 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>GitLab Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736792117_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for GitLab has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing GitLab's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, GitLab's peer group average for short interest as a percentage of float is 5.22%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

GTLB

How Is The Market Feeling About GitLab?

Morgan Stanley analyst Elizabeth Porter maintains Sprout Social (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPT#NASDAQ">SPT</a>) with a Equal-Weight and raises the price target from $36 to $37.

Morgan Stanley Maintains Equal-Weight on Sprout Social, Raises Price Target to $37

Summit Materials's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUM#NYSE">SUM</a>) short percent of float has risen 14.44% since its last report. The company recently reported that it has 6.59 million shares sold short, which is 5.47% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.94 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Summit Materials Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736792112_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Summit Materials has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Summit Materials's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Summit Materials's peer group average for short interest as a percentage of float is 2.96%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(SUM) - Analyzing Summit Materials's Short Interest

Morgan Stanley analyst Stefan Diaz maintains Sealed Air (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEE#NYSE">SEE</a>) with a Equal-Weight and lowers the price target from $39 to $38.

Morgan Stanley Maintains Equal-Weight on Sealed Air, Lowers Price Target to $38

Morgan Stanley analyst Matthew Cost maintains Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) with a Overweight and raises the price target from $65 to $75.

RBLX

Morgan Stanley Maintains Overweight on Roblox, Raises Price Target to $75

Morgan Stanley analyst Brian Nowak maintains Pinterest (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>) with a Equal-Weight and raises the price target from $35 to $36.

PINS

Morgan Stanley Maintains Equal-Weight on Pinterest, Raises Price Target to $36

Morgan Stanley analyst Angel Castillo maintains Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) with a Underweight and lowers the price target from $41 to $31.

Morgan Stanley Maintains Underweight on Olin, Lowers Price Target to $31

Morgan Stanley analyst Nigel Dally maintains Mosaic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOS#NYSE">MOS</a>) with a Equal-Weight and lowers the price target from $40 to $30.

Morgan Stanley Maintains Equal-Weight on Mosaic, Lowers Price Target to $30

Morgan Stanley analyst Brian Nowak maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Overweight and raises the price target from $600 to $660.

Morgan Stanley Maintains Overweight on Meta Platforms, Raises Price Target to $660

Morgan Stanley analyst Nathan Feather maintains Match Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ">MTCH</a>) with a Equal-Weight and raises the price target from $31 to $32.

MTCH

Morgan Stanley Maintains Equal-Weight on Match Group, Raises Price Target to $32

Citigroup analyst Andrew Kaplowitz maintains Xylem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYL#NYSE">XYL</a>) with a Buy and lowers the price target from $148 to $147.

Citigroup Maintains Buy on Xylem, Lowers Price Target to $147

Morgan Stanley analyst Vincent Andrews maintains LyondellBasell Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYB#NYSE">LYB</a>) with a Overweight and lowers the price target from $110 to $90.

Comments

Cannabis Suisse

Vendite allo scoperto

Cannabis Suisse (OTC:CSUI) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO